Primary Ewing's sarcoma presenting as a Pancoast tumourVANFLETEREN, Lowie; VAN STIPHOUT, Rogier; RIEDL, Robert G et al.Thorax. 2011, Vol 66, Num 1, pp 89-90, issn 0040-6376, 2 p.Article

Validation of a polymerase chain reaction aided transcript titration assay (PATTY) for topoisomerase II in lung cancer samplesDINGEMANS, Anne-Marie C; VAN ARK-OTTE, Jannette; SMIT, Egbert F et al.Anticancer research. 2000, Vol 20, Num 5B, pp 3549-3554, issn 0250-7005Article

[¹⁸F]FLUORODEOXYGLUCOSE UPTAKE PATTERNS IN LUNG BEFORE RADIOTHERAPY IDENTIFY AREAS MORE SUSCEPTIBLE TO RADIATION-INDUCED LUNG TOXICITY IN NON-SMALL-CELL LUNG CANCER PATIENTSPETIT, Steven F; VAN ELMPT, Wouter J. C; OBERIJE, Cary J. G et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 3, pp 698-705, issn 0360-3016, 8 p.Article

Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?HENDRIKS, Lizza E. L; BOOTSMA, Gerben P; DE RUYSSCHER, Dirk K. M et al.Lung cancer. 2013, Vol 80, Num 3, pp 293-297, issn 0169-5002, 5 p.Article

Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non-Small-Cell Lung CancerVAN BAARDWIJK, Angela; WANDERS, Stofferinus; LAMBIN, Philippe et al.Journal of clinical oncology. 2010, Vol 28, Num 8, pp 1380-1386, issn 0732-183X, 7 p.Article

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patientsHEUVERS, Marlies E; MUSKENS, Femke; BEZEMER, Koen et al.Lung cancer. 2013, Vol 81, Num 3, pp 468-474, issn 0169-5002, 7 p.Article

Deletions of 11q22.3-q25 Are Associated with Atypical Lung Carcinoids and Poor Clinical OutcomeSWARTS, Dorian R. A; CLAESSEN, Sandra M. H; VINK, Aryan et al.The American journal of pathology. 2011, Vol 179, Num 3, pp 1129-1137, issn 0002-9440, 9 p.Article

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung CancerSMIT, Egbert F; BURGERS, Sjaak A; GROEN, Harry J. M et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 2038-2045, issn 0732-183X, 8 p.Article

Nuclear transcription factor κB activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexiaDEN KAMP, Céline M.op; LANGEN, Ramon C; SNEPVANGERS, Frank J et al.The American journal of clinical nutrition. 2013, Vol 98, Num 3, pp 738-748, issn 0002-9165, 11 p.Article

Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: A prospective population-based studyWANDERS, Rinus; STEEVENS, Jessie; GERAEDTS, Wiel et al.European journal of cancer (1990). 2011, Vol 47, Num 18, pp 2691-2697, issn 0959-8049, 7 p.Article

SELECTIVE NODAL IRRADIATION ON BASIS OF ¹⁸FDG-PET SCANS IN LIMITED-DISEASE SMALL-CELL LUNG CANCER: A PROSPECTIVE STUDYVAN LOON, Judith; DE RUYSSCHER, Dirk; PITZ, Cordula et al.International journal of radiation oncology, biology, physics. 2010, Vol 77, Num 2, pp 329-336, issn 0360-3016, 8 p.Article

What to choose as radical local treatment for lung metastases from colo-rectal cancer: Surgery or radiofrequency ablation?SCHLIJPER, Roel C. J; GRUTTERS, Janneke P. C; DE RUYSSCHER, Dirk et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 60-67, issn 0305-7372, 8 p.Article

Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancerBAARDWIJK, Angela Van; REYMEN, Bart; PETERS, Frank et al.European journal of cancer (1990). 2012, Vol 48, Num 15, pp 2339-2346, issn 0959-8049, 8 p.Article

¹⁸FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluationVAN LOON, Judith; GRUTTERS, Janneke P. C; SNOEP, Gabriel et al.European journal of cancer (1990). 2010, Vol 46, Num 1, pp 110-119, issn 0959-8049, 10 p.Article

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non―Small Cell Lung Cancer with a KRAS MutationDINGEMANS, Anne-Marie C; MELLEMA, Wouter W; GROEN, Harry J. M et al.Clinical cancer research (Print). 2013, Vol 19, Num 3, pp 743-751, issn 1078-0432, 9 p.Article

CD44 and OTP Are Strong Prognostic Markers for Pulmonary CarcinoidsSWARTS, Dorian R. A; HENFLING, Mieke E. R; VAN CRIEKINGE, Wim et al.Clinical cancer research (Print). 2013, Vol 19, Num 8, pp 2197-2207, issn 1078-0432, 11 p.Article

A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non-Small Cell Lung CancerLIND, Joline S. W; DINGEMANS, Anne-Marie C; VAN SUYLEN, Robert Jan et al.Clinical cancer research (Print). 2010, Vol 16, Num 11, pp 3078-3087, issn 1078-0432, 10 p.Article

Topoisomerase IIα and other drug resistance markers in advanced non-small cell lung cancerDINGEMANS, Anne-Marie C; VAN ARK-OTTE, Jannette; SPAN, Simone et al.Lung cancer. 2001, Vol 32, Num 2, pp 117-128, issn 0169-5002Article

Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer ― EORTC 08062MARY, O'brien; KRZYSTOF, Konopa; BAKTIAR, Hasan et al.European journal of cancer (1990). 2011, Vol 47, Num 15, pp 2322-2330, issn 0959-8049, 9 p.Article